Prostate Size: What’s Normal, What’s Large
Volume tells your doctor which treatments are available to you, and surprisingly little about how bad your symptoms will be. Those are two separate questions.
Find out in under a minute – no phone call needed.
On this page
A report gives your prostate volume in millilitres and no context at all. The useful answer is that size tells your doctor which treatments are available to you, and surprisingly little about how bad your symptoms will be. Those are two separate things, and conflating them causes most of the confusion around this number.
Normal Size by Age
A young adult prostate is roughly 20 to 25 mL — about a walnut. It begins a second phase of growth in the mid-twenties and continues slowly for the rest of life, driven by hormonal changes within the gland rather than by anything you did.
Community data from nearly 1,800 men without significant urinary complaints found mean prostate volume rising from about 24 mL at age 50 to 38 mL by age 80. Over the same span, mean PSA rose from 1.1 to 2.5 ng/mL and mean IPSS from 4 to 7. In other words, a prostate somewhat larger than a young man’s is the normal state of affairs in an older man, not a diagnosis.
What Counts as Enlarged
Within normal range
Typical for a younger man, and still common into middle age.
Treatment relevance: A prostate this size is rarely the cause of significant obstruction. Symptoms here point elsewhere.
Mildly enlarged
Very common with age. Can obstruct meaningfully depending on where the growth sits.
Treatment relevance: All treatment options remain open.
Moderately enlarged
Frequently symptomatic, and the range most minimally invasive treatments were designed around.
Treatment relevance: Still within range for most options, approaching the limits of some.
Large
The threshold beyond which the device-based treatments were largely not studied.
Treatment relevance: UroLift generally excluded, Rezum less durable, TURP more difficult. HoLEP, simple prostatectomy, and PAE remain.
The 80 mL line gets quoted constantly, so it is worth being clear about what it is. It is not a point at which anything changes biologically. It is the edge of where most of the newer devices were tested.
Why Size Predicts Symptoms Poorly
This is the part that surprises people. Studies looking at prostate volume against IPSS consistently find only a weak relationship — correlation coefficients around 0.1 to 0.2, often not statistically significant. One large community study concluded outright that prostate size had only a minor impact on symptom scores, and another that volume alone is not useful for estimating disease severity.
In practice this means men with 80 mL prostates sometimes have mild symptoms, and men with 30 mL prostates sometimes have severe ones. If you have a large prostate and feel fine, that is a recognised pattern rather than luck. If you have a modest prostate and feel terrible, you are not exaggerating.
What Matters More Than Size
- Where the growth sits. Tissue growing inward against the urethra obstructs far more than the same volume growing outward.
- Median lobe and intravesical protrusion. A lobe bulging up into the bladder acts like a ball valve. Protrusion beyond about 10 mm can cause severe obstruction from a gland of otherwise unremarkable size — and it also determines which treatments will work.
- Bladder function. After years of pushing against resistance, the bladder muscle can weaken. Symptoms then persist even after the obstruction is relieved, which is one reason not to wait indefinitely.
- Flow rate and residual urine. These measure what is actually happening, rather than inferring it from anatomy.
So if your volume seems mismatched to how you feel, ask whether you have a median lobe and what your flow rate and post-void residual are. Those three facts explain most mismatches.
How It Gets Measured
- Digital rectal exam gives a rough estimate. Quick, but it only reaches the back surface of the gland and consistently underestimates large prostates.
- Transrectal ultrasound is the common accurate method.
- MRI is the most precise, and shows median lobe anatomy and intravesical protrusion clearly. It is also what tends to be used when planning treatment.
Different methods give different numbers for the same gland, so a change between two reports may reflect the technique rather than real growth. When comparing, check that both used the same method.
When Size Actually Decides Treatment
Size matters less for whether you need treatment and a great deal for which treatments you can have. Symptoms and bother determine the first; volume largely determines the second.
Under 80 mL, essentially everything is available. Above it, options narrow: UroLift is generally excluded, Rezum becomes less durable, TURP becomes technically harder. What remains are HoLEP, simple prostatectomy, and PAE — and only PAE among these is a same-day procedure without general anesthesia. Our page on large prostates and surgery covers that situation in detail.
Worth knowing: PSA rises with prostate volume — the two correlate reasonably well. A modestly elevated PSA in a man with a large prostate often reflects the size of the gland rather than anything sinister, though that is a judgment for your doctor with your full picture in front of them.
Where Prostate Artery Embolization Fits
PAE treats an enlarged prostate from the inside of the blood vessels rather than through the urethra. A catheter is threaded from a pinhole in the wrist or groin to the small arteries feeding the prostate, and microscopic particles are released to reduce its blood supply. The gland shrinks over the following months and the pressure on the urethra eases. There is no incision, no general anesthetic, no instrument passed through the penis, and no overnight stay.
Because it works through the arteries instead of the prostatic urethra, PAE avoids the bladder neck entirely. That anatomical difference is why it behaves so differently from the transurethral procedures on the one measure men care about most and are least often asked about.
That last figure belongs here rather than buried. PAE trades durability for safety and functional preservation. Around one man in five needs something further within five years, against a much lower rate after resective surgery. In the largest long-term series, 88% of men had still avoided prostatectomy at five years, and a repeat PAE kept most of those who needed more treatment out of surgery altogether. Whether that trade is worth it depends on what you are optimising for, and it is a legitimate reason some men choose TURP or HoLEP instead.
PAE entered the American Urological Association guideline in the 2023 amendment, and the European Association of Urology guideline the same year. The previous AUA guideline had recommended against it outside clinical trials, so this is a genuine change in standing rather than marketing language — and it is the reason insurance coverage has improved. Our insurance page covers how we handle authorisation, and the office can check your benefits directly.
California Prostate Center
Atabak Allaei, MD
- Double board-certified in Vascular & Interventional Radiology and Diagnostic Radiology
- Attending staff at Cedars-Sinai Medical Center and UCI Health
- More than 10,000 image-guided procedures performed
- Focused practice in prostate artery embolization, including large glands and men who are poor candidates for surgery
Appointments in Beverly Hills, Pomona, and Orange County, or by video telehealth. Bring your prostate volume measurement, recent PSA, and IPSS score if you have them.
Common Questions
What is a normal prostate size?
About 20 to 25 mL in a young adult man. It grows slowly with age: community data show mean volume rising from roughly 24 mL at age 50 to 38 mL at age 80 in men without significant urinary symptoms. Enlargement with age is normal rather than a diagnosis in itself.
Is a 60 gram prostate big?
It is moderately enlarged — larger than average, well within the range most treatments were designed for. Whether it needs treating depends on your symptoms and flow, not the number. Plenty of men with 60 mL prostates have mild symptoms.
Does a bigger prostate mean worse symptoms?
Can the prostate shrink?
Not on its own, and not with diet or supplements. Finasteride and dutasteride reduce volume modestly over months. Procedures that remove, destroy, or devascularise tissue reduce it more substantially — PAE typically reduces volume by roughly 20 to 30%.
Does a large prostate mean higher cancer risk?
BPH is not cancer and does not turn into it. A large gland does raise PSA, which can complicate interpretation of that test, since volume and PSA correlate. Cancer risk is assessed with PSA in context, examination, and imaging — not from size alone.
References
- Berges R, Oelke M. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older. World J Urol. 2011;29(2):171–178.
- Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2003;37(4). Prostate volume correlated with PSA (r = 0.54); prostate volume alone is not useful in estimating disease severity.
- Correlation between prostate volume measured by ultrasound and symptom severity score in patients with BPH. Weak positive correlation between prostate volume and IPSS (r = +0.109).
- Prostatic arterial embolization for LUTS due to large (>80 mL) BPH. Average reduction in prostatic volume after PAE varies from 20% to 32%.
This article is for general education and does not replace an evaluation by a qualified physician. Individual results vary. See our disclaimer.
Find out whether PAE fits your prostate
Dr. Allaei reviews your imaging, PSA and symptom scores himself and tells you plainly whether embolization suits your anatomy, what to expect, and when another treatment is the better answer.
